Interestingly, the WWOX/HIF1A ratio appears to be associated with prognosis in patients with various subtypes of breast cancer, brain tumours, and HCC, suggesting it may impact important biological processes in these cancers. This evidence concerns the gene HIF1A and hepatocellular carcinoma.